Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model

Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model

AIM:To compare the efficacies of subconjunctival bevacizumab, ranibizumab, and pegaptanib sodium injections for the inhibition of corneal neovascularization in an experimental rat model.METHODS:Sixteen corneas of 16 rats were chemically cauterized and randomized into four groups:bevacizumab group th...

Full description

Bibliographic Details
Main Authors: Cem Küçükerdönmez, Veysi Öner, Ebru Eren Akar, Yonca Aydın Akova
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2013-04-01
Series:International Journal of Ophthalmology
Subjects:
corneal neovascularization
bevacizumab
ranibizumab
pegaptanib
subconjunctival injection
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633748/

Internet

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633748/

Similar Items